Global health measures from a National Down Syndrome Registry
暂无分享,去创建一个
[1] K. Donelan,et al. Health in Down syndrome: creating a conceptual model. , 2023, Journal of intellectual disability research : JIDR.
[2] S. Santoro,et al. Indicators of health in Down syndrome: A virtual focus group study with patients and their parents. , 2023, Journal of applied research in intellectual disabilities : JARID.
[3] S. Cullen,et al. Healthcare experiences of patients with Down syndrome who are Black, African American, of African descent, or of mixed race , 2022, American journal of medical genetics. Part A.
[4] K. Donelan,et al. Proxy-report in individuals with intellectual disability: A scoping review. , 2022, Journal of applied research in intellectual disabilities : JARID.
[5] K. Donelan,et al. Piloting the use of global health measures in a Down syndrome clinic. , 2021, Journal of applied research in intellectual disabilities : JARID.
[6] J. Pell,et al. Birth incidence, deaths and hospitalisations of children and young people with Down syndrome, 1990–2015: birth cohort study , 2020, BMJ Open.
[7] C. Goldfarb,et al. Patient-reported Outcomes in Arthrogryposis , 2020, Journal of pediatric orthopedics.
[8] S. Davis,et al. A mixed methods study of physical activity and quality of life in adolescents with Turner syndrome , 2019, American journal of medical genetics. Part A.
[9] C. Velozo,et al. Comparative study of PROMISⓇ self-efficacy for managing chronic conditions across chronic neurologic disorders , 2019, Quality of Life Research.
[10] S. Cooper,et al. Prevalence of physical conditions and multimorbidity in a cohort of adults with intellectual disabilities with and without Down syndrome: cross-sectional study , 2018, BMJ Open.
[11] M. Digilio,et al. Health Supervision for Children With Down Syndrome , 1994, Pediatric Clinical Practice Guidelines & Policies.
[12] B. Skotko,et al. Estimation of the number of people with Down syndrome in the United States , 2016, Genetics in Medicine.
[13] C. Forrest,et al. Concurrent validity of the PROMIS® pediatric global health measure , 2016, Quality of Life Research.
[14] M. Oster-Granite,et al. DS-Connect: A Promising Tool to Improve Lives and Engage Down Syndrome Communities Worldwide. , 2015, Global heart.
[15] P. Hinds,et al. PROMIS® pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions , 2015, Quality of Life Research.
[16] Peter D. Bulova,et al. Managing the care of adults with Down’s syndrome , 2014, BMJ : British Medical Journal.
[17] C. Forrest,et al. Development of the PROMIS® pediatric global health (PGH-7) measure , 2014, Quality of Life Research.
[18] O. Devine,et al. Current estimate of Down Syndrome population prevalence in the United States. , 2013, The Journal of pediatrics.
[19] Jianhua Wu,et al. The population prevalence of Down’s syndrome in England and Wales in 2011 , 2013, European Journal of Human Genetics.
[20] E. Perrin,et al. Quality of life of adolescents with autism spectrum disorders: concordance among adolescents’ self-reports, parents’ reports, and parents’ proxy reports , 2012, Quality of Life Research.
[21] J. Fries,et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH Roadmap Cooperative Group During its First Two Years , 2007, Medical care.
[22] C. Disteche,et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[23] Kazuhiro Ishii,et al. [Down syndrome]. , 2003, Ryoikibetsu shokogun shirizu.